We studied 503 patients (mean age 74 ± 10 years) with severe AS (indexed aortic valve area 0.4 ± 0.1 cm 2 /m 2 , left ventricular ejection fraction 57 ± 12%) undergoing left and right heart catheterization prior to aortic valve replacement. Median follow-up was 3.7 (interquartile range 2.6-5.4) years. Baseline PH (mean pulmonary artery pressure ≥ 25 mmHg) was found in 239 (48%) patients: 31 patients had pre-capillary PH [mean pulmonary artery wedge pressure (mPAWP) ≤ 15 mmHg], 144 had isolated post-capillary PH [IpcPH; mPAWP > 15 mmHg, pulmonary vascular resistance (PVR) ≤ 3 Wood units (WU)], and 64 had combined pre-and post-capillary PH (CpcPH; mPAWP > 15 mmHg, PVR > 3 WU). Patients with CpcPH had higher mortality than those with IpcPH, pre-capillary PH, and without PH. In the multivariate analysis, CpcPH remained an independent predictor of death (hazard ratio 4.39, 95% confidence interval 2.40-8.03; P < 0.001). Patients with CpcPH had higher mPAWP (26 ± 7 vs. 22 ± 5 mmHg) and lower pulmonary arterial capacitance (1.5 ± 0.6 vs. 2.9 ± 1.2 mL/mmHg) than IpcPH patients but similar left ventricular end-diastolic pressure (LVEDP; 25 ± 7 vs. 25 ± 7 mmHg). A smaller LVEDP-mPAWP difference was related to larger left atrial size, atrial fibrillation, and more severe mitral regurgitation.
Introduction
Pulmonary hypertension (PH) due to left heart disease is the most common form of PH. 1 In patients with severe aortic stenosis regurgitation velocity. This together with indirect signs of PH gives a reasonable estimate of the probability of significant PH 7 but does not allow assessing the underlying haemodynamic mechanisms of PH in detail. 8 Studies in patients with heart failure (HF) not related to AS [i.e. patients with HF with reduced or preserved left ventricular ejection fraction (LVEF)] have revealed two different haemodynamic patterns of PH with significantly different prognosis. 9 -11 The most common form is isolated post-capillary PH (IpcPH), i.e. PH solely driven by elevated left-sided filling pressures and defined by an elevated mean pulmonary artery wedge pressure (mPAWP) but a normal pulmonary vascular resistance (PVR) and diastolic pressure gradient (DPG). 7, 9, 11 Ten to 15% of patients, however, have combined pre-and post-capillary PH (CpcPH), which is characterized by high filling pressures in combination with a pulmonary vascular component of PH and is defined by the combination of elevated mPAWP and PVR and/or DPG. 7, 11 This form of PH shares similarities with pulmonary arterial hypertension (PAH) and is associated with poor prognosis. 9, 11 In the only available larger and detailed invasive study in patients with AS, O'Sullivan et al. 12 found PH in 75% of 433 patients with severe AS undergoing transcatheter aortic valve replacement (AVR). Approximately 20% had CpcPH, and these patients had worse 1-year mortality than patients without PH and patients with IpcPH. The comparison of this study with the current literature is somewhat limited by the fact that left ventricular end-diastolic pressure (LVEDP) rather than mPAWP was used for the definition of post-capillary PH, 12 although discrepancies between LVEDP and mPAWP are well known and may be clinically meaningful.
13 -15 In addition, pulmonary arterial capacitance (PAC) has emerged as an important haemodynamic parameter characterizing CpcPH.
11,16 -18 However, there are currently no data on PAC in patients with AS.
In the present study, we aimed to assess the prevalence, haemodynamic mechanisms, and long-term prognostic impact of PH in a large cohort of patients with severe AS undergoing right heart catheterization prior to AVR. In particular, we evaluated the role of PAC and the LVEDP vs. mPAWP relationship.
Methods

Study population
We studied consecutive patients with severe AS undergoing cardiac catheterization in a single centre between January 2011 and January 2016 prior to AVR. This is a retrospective study of prospectively and systematically collected data on cardiac catheterization. The study was approved by the local ethics committee.
Cardiac catheterization
Patients underwent coronary angiography using 5 or 6 French catheters by femoral or radial approach and right heart catheterization using 6 French Swan-Ganz catheters by femoral or brachial access. Systolic, diastolic, and mean PAP (mPAP) and mPAWP were measured. Measurements were obtained at end-expiration, mPAWP was calculated over the entire cardiac cycle, and V waves were included . to determine mPAWP. In patients with atrial fibrillation at least five cardiac cycles were used to assess PAP and mPAWP. Cardiac output (CO) was assessed by the indirect Fick method. The transpulmonary gradient (TPG) was calculated as mPAP-mPAWP. PVR was calculated as TPG/CO, DPG was calculated as diastolic PAP-mPAWP, and PAC was calculated as stroke volume/(systolic PAP-diastolic PAP), where stroke volume is CO/heart rate. If the aortic valve was crossed, which was at the discretion of the invasive cardiologist, LVEDP was recorded.
Haemodynamic definitions
Pulmonary hypertension was defined as mPAP ≥ 25 mmHg and was classified as pre-capillary [mPAWP ≤ 15 mmHg), IpcPH [mPAWP > 15 mmHg, PVR ≤ 3 Wood units (WU)], or CpcPH (mPAWP > 15 mmHg, PVR > 3 WU). 7 Given the recent controversy about using the DPG for the definition of CpcPH 10 and the availability of diastolic PAP in only 97% of the population, we decided to use only the PVR criterion.
Follow-up
All patients underwent surgical AVR (72%) or transcatheter AVR (28%). Information on long-term follow-up was obtained from patients, general practitioners, and hospital or practice cardiologists. The endpoint was all-cause mortality.
Statistical analysis
Categorical data are presented as numbers and percentages, and continuous data are given as mean ± standard deviation, or median (interquartile range) as appropriate. Patients without PH, and those with pre-capillary PH, IpcPH, and CpcPH were compared using chi-square tests, analysis of variance (ANOVA), or Kruskal-Wallis test with appropriate post-hoc tests. For correlations of interest, Pearson or Spearman correlation coefficients were calculated. Survival of patients without PH, and those with pre-capillary PH, IpcPH, and CpcPH was compared using Kaplan-Meier plots and log-rank tests. Multivariate Cox regression was performed to assess independent predictors of mortality. Covariates associated with mortality in the univariate analysis (P < 0.1) were entered into the multivariate model. Similarly, Kaplan-Meier plots were constructed to compare survival according to haemodynamic parameters of interest, and a multivariate model was constructed to define the prognostic value of PAC and PVR. Receiver operating characteristic curves were constructed to compare the areas under the curve for the prediction of death of covariates of interest. A P-value < 0.05 was considered statistically significant. All analyses were performed using SPSS statistical package version 20.0 (SPSS Inc., Chicago, IL, USA).
Results
The study population consisted of 503 patients (mean age 74 ± 10 years, 58% males). The mean indexed aortic valve area was 0.4 ± 0.1 cm 2 /m 2 , and the mean LVEF was 57 ± 12%. In the entire population, 239 (48%) patients had PH. Among these 239 patients, 31 had pre-capillary PH, 144 had IpcPH, and 64 had CpcPH. 
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Data are given as number (%), mean ± standard deviation, or median (interquartile range). AVA, aortic valve area; CAD, coronary artery disease; CpcPH, combined pre-and post-capillary pulmonary hypertension; dPAP, diastolic pulmonary artery pressure; IpcPH, isolated post-capillary pulmonary hypertension; LVEDD, left ventricular end-diastolic diameter; LVEDP, left ventricular end-diastolic pressure; LVEF, left ventricular ejection fraction; LVMI, left ventricular mass index; mPAP, mean pulmonary artery pressure; mPAWP, mean pulmonary artery wedge pressure; PAC, pulmonary arterial capacitance; PH, pulmonary hypertension; PVR, pulmonary vascular resistance; sPAP, systolic pulmonary artery pressure; SVR, systemic vascular resistance; TAPSE, tricuspid annular plane systolic excursion. 
Clinical outcomes
After a median follow-up of 3.7 (2.6-5.4) years there were 45 deaths. Causes of death were perioperative/periprocedural within the first 30 days (n = 19), cancer (n = 4), infection (n = 1), . . . . . . . . . . . . . . . cardiovascular (n = 4), and unknown (n = 17). Patients with CpcPH had higher mortality than patients without PH, while mortality in patients with IpcPH and pre-capillary PH did not significantly differ from those without PH (Figure 1) . In Table 3 , predictors of death according to the univariate analysis are shown. In the multivariate Figure 1 Kaplan-Meier plot comparing survival in patients without pulmonary hypertension (PH), and with pre-capillary PH, isolated post-capillary PH (IpcPH) and combined pre-and post-capillary PH (CpcPH). analysis, only the presence of CpcPH (more than four-fold relative risk compared to patients without CpcPH) and a lower mean aortic valve gradient were independent predictors of death.
Pulmonary vascular resistance vs. pulmonary arterial capacitance relationship
In the 487 patients (97% of the entire population) with complete data on systolic and diastolic PAP and stroke volume, the median . Table 2 ). There was a non-linear, hyperbolic relationship between PAC and PVR ( Figure 2A) . The product of PAC and PVR forms a constant, the pulmonary arterial time constant (RC time). Figure 2B shows that RC time depends on PAWP, i.e. the RC time is lower the higher the mPAWP. As shown in the online supplementary Figure S1 , there is a downward-leftward shift of the PVR-PAC relationship with higher mPAWP indicating that for a fix PVR, PAC is lower with higher mPAWP.
Prognostic role of pulmonary vascular resistance and pulmonary arterial capacitance
Patients with inframedian PAC (n = 242) were older, had lower LVEF, TAPSE, and indexed aortic valve area, and had higher mPAP, mPAWP and PVR than those with supramedian PAC (n = 245) (data not shown, P < 0.05 for all). In Figure 3 , the prognostic impact of mPAWP, PVR, and PAC is illustrated. All three parameters (separation according to the median, Figure 3A- Table S2 ) were independent predictors of death. The receiver operating characteristic curve ( Figure 3D) shows that PAC had the numerically higher area under the curve for the prediction of death than PVR. The optimal PVR cut-off of 1.74 WU had a sensitivity of 64% and a specificity of 67% for the prediction of death. The optimal PAC cut-off of 2.49 mmHg/mL had a sensitivity of 64% and a specificity of 69% for the prediction of death.
Left ventricular end-diastolic pressure vs. mean pulmonary artery wedge pressure relationship
Data for both LVEDP and mPAWP were available in 340 patients (68%). As shown in Table 2 , there was a divergence between LVEDP and mPAWP, and this difference between LVEDP and mPAWP (calculated as LVEDP-mPAWP to avoid predominantly negative values) was largest in patients without PH and smallest in those with CpcPH. Thus, patients with IpcPH and CpcPH had similar LVEDP but mPAWP was higher and closer to LVEDP in those with CpcPH. As expected, there were significant inverse correlations between a lower LVEDP-mPAWP difference and a higher mPAP and mPAWP, and significant direct correlations between a lower LVEDP-mPAWP difference and a lower LVEF and indexed aortic valve area (data not shown). In addition, a lower LVEDP-mPAWP difference was related to larger left atrial area (r = -0.22; P = 0.01), more severe mitral regurgitation (r = -0.23; P < 0.001), higher heart rate (r = -0.16; P = 0.003), and presence of atrial fibrillation (r = -0.36; P < 0.001).
Discussion
The present study evaluating the invasive haemodynamics of consecutive patients with severe AS revealed several novel findings. First, nearly 50% of these patients have PH. Second, one quarter of patients with PH have CpcPH, which in contrast to IpcPH is associated with increased mortality. Third, similarly to patients with HF and reduced LVEF, PAC is inversely related to mPAWP and is a predictor of death. And fourth, CpcPH and IpcPH patients have similar LVEDP but mPAWP is higher and closer to LVEDP in those with CpcPH, a phenomenon which is related to larger left atrial size, more severe mitral regurgitation, and presence of atrial fibrillation.
Prevalence of pulmonary hypertension and combined pre-and post-capillary pulmonary hypertension
The difference in PH prevalence between the study by O'Sullivan et al. 12 and ours (75% vs. 48%) is likely explained by the fact that we studied a population with a broad disease spectrum, while the O'Sullivan 12 population was approximately 8 years older and a pure transcatheter AVR population. Additionally, the proportion of patients with CpcPH was higher in our study (28% vs. 15%), which may have been at least in part due to different definitions of post-capillary PH and CpcPH, respectively: O'Sullivan et al. 12 used LVEDP as a substitute for mPAWP, and they used DPG to separate CpcPH from IpcPH. However, our study has confirmed previous data that LVEDP and mPAWP may significantly differ, 13 -15 which has implications for the differentiation of pre-capillary vs. post-capillary PH as well as calculation of DPG. For the definition of CpcPH, guidelines suggest using the criterion of a PVR > 3 WU and/or DPG ≥ 7 mmHg, 7 while we used the PVR criterion only. This practice is supported by two recent studies: Palazzini et al. 19 demonstrated that among patients with PH due to left heart disease (mixed aetiologies) those fulfilling both the PVR and the . . DPG criteria and those fulfilling only one criterion had similar survival, which was worse than that of patients with IpcPH (no criterion met). Importantly, almost all patients fulfilling the DPG criterion also fulfilled the PVR criterion, while only 40% of patients with PVR > 3 WU also had DPG ≥ 7 mmHg. 19 Similarly to our results, they showed that PVR predicted outcome while DPG did not. 19 A very recent study looking at resting and exercise haemodynamics in patients with HF with preserved LVEF 20 used the definition to separate CpcPH and IpcPH according to guidelines. 7 However, all patients with CpcPH fulfilled the PVR criterion while only a minority fulfilled the DPG criterion. 20 Importantly, CpcPH and IpcPH patients exhibited a clearly distinct exercise response, 20 indirectly justifying the practice of preferring the PVR criterion. Interestingly, we found a high proportion of patients with negative DPG (as evident from the data in Table 2 ), which is in line with the findings from patients with mitral stenosis and PH due to HF with reduced or preserved ejection fraction as reported by Nagy et al. 21 They showed that negative DPG values were associated with the presence of large V waves in patients with PVR < 3 WU. In our study, as in the study by Nagy et al., 21 mPAWP was obtained from the entire cardiac cycle including V waves. This probably has resulted in higher mPAWP values compared to a practice of not including V waves, which in turn has resulted in lower DPG, TPG, and PVR values.
Prognostic importance of combined pre-and post-capillary pulmonary hypertension
A main finding of the present study is the strong prognostic impact of the presence of CpcPH in AS. The CpcPH group had the worst right ventricular function as expressed by TAPSE, an established prognostic marker in various settings, 22 -24 and reflected by the highest right atrial pressure and right ventricular end-diastolic pressure. The presence of right ventricular dysfunction represents the most advanced stage of AS, which is associated with poor prognosis. 3 There is relatively recent evidence that in patients with severe AS, PH often persists after AVR, 5, 6 and that post-AVR PH is a more important prognostic predictor than pre-AVR PH. 5 Since this information is derived from echocardiographic studies, the detailed haemodynamic pattern prior and post AVR of these patients remains unknown. We hypothesize that these patients with persistent PH after AVR may have had CpcPH beforehand but this remains to be shown in future studies. Therefore, prevention of CpcPH in patients with AS is of utmost importance to prevent right ventricular dysfunction and death.
Critical role of filling pressures and pulmonary vascular remodelling
Little is known about the factors leading to the transition from IpcPH to CpcPH. The genetic background 25 as well as co-morbidities may play a role, although this remains speculative. However, the extent and chronicity of backwards transmission of left-sided filling pressures are thought to represent the key drivers for the transition from IpcPH to CpcPH. 1, 9, 26 This view is supported by our data showing that patients with CpcPH not only have higher PVR but also higher mPAWP than patients with IpcPH. Interestingly, we found no difference in LVEDP between the CpcPH and IpcPH groups, i.e. the CpcPH group was characterized by a smaller difference between LVEDP and mPAWP indicating that left ventricular pressure is more strongly reflected backwards into the pulmonary circulation. We further found that a smaller LVEDP-mPAWP difference was related to a larger left atrial size, presence of atrial fibrillation, and more severe mitral regurgitation, which may point to a critical role of left atrial dysfunction and/or mitral regurgitation in keeping left atrial pressure and mPAWP respectively high and driving the development of CpcPH. In addition, for the first time we present data on PAC in patients with AS and PH. In contrast to PVR, PAC takes into account the pulsatility . We found a very similar PAC vs. PVR relationship indicating that the relatively small increase in PVR seen in patients with AS fulfilling the criterion for CpcPH already represents a large decrease in PAC. We also found an inverse relationship between PAC and PAWP. This means that the pulsatile load to the right ventricle rises (lower PAC) with rising PAWP. Patients with lower PAC had worse right ventricular function and worse survival, and PAC was as least as good as PVR and PAWP for the prediction of death, most likely because PAC combines the information from PVR and PAWP.
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Clinical implications
It is evident that CpcPH represents an advanced state of pulmonary vascular disease in AS. The feasibility of the normalization of elevated PVR, i.e. reversal of CpcPH by left ventricular assist device-mediated unloading of the left ventricle in transplant candidates with HF with reduced LVEF and CpcPH, has been demonstrated 28 suggesting that the main concept to treat CpcPH is to lower PAWP aggressively. However, left atrial pressure not directly depends on AS but on its consequences on the left ventricle and left atrium. 29 Therefore, prevention of left ventricular and left atrial remodelling by timely AVR is highly important. Still, at the time of AVR irreversible changes to the left ventricle may have occurred, lowering of mPAWP may be very difficult at that time, and therefore intense research activities in the role of early pharmacological interventions targeting the left ventricle and left atrium (e.g. angiotensin-converting enzyme inhibitors, mineralocorticoid receptor antagonists) are needed. Importantly, there is no evidence for a beneficial effect of PAH-specific therapies for the management of patients with PH due to left heart disease; the opposite may even be the case. 26 Very recently, a randomized trial evaluating the effect of the phosphodiesterase-5 inhibitor sildenafil in patients with persistent PH several months after valve replacement/repair (median mPAP 39 mmHg, median PVR 3.4 WU) found worse clinical outcomes (death, hospital admission, worsening functional class, global symptom burden) in patients treated with sildenafil compared to placebo. 30 The study included patients with both IpcPH and CpcPH but the effect of sildenafil was similar in both groups.
Limitations
First, although this is one of largest studies on invasive haemodynamics in AS, the number of patients was still moderate. Second, data on cardiac catheterization were obtained from reports rather than directly from pressure tracings. However, our centre has a long tradition in measuring invasive haemodynamics in patients with valve disease, and all cardiologists performing these examinations were experienced in this regard. Third, the calculation of cardiac output based on an estimate of oxygen consumption (indirect Fick method) is subject to error, 31 which may have had impact on all cardiac output-and stroke volume-derived measures including PAC. However, measurement of oxygen consumption is not possible in clinical routine, and the indirect Fick method is established in clinical practice. Fourth, although all patients had an echocardiogram, not all studies were systematically performed at our institution. We had access to the available relevant data, but not all parameters of interest were measured in a systematic manner.
Conclusions
In patients with severe AS, PH is common but underlying mechanisms differ. Patients with CpcPH have higher mPAWP, lower PAC, and worse survival than all other groups. Left atrial dysfunction and mitral regurgitation seem to be drivers of high mPAWP in CpcPH.
Supplementary Information
Additional supporting information may be found online in the Supporting Information section at the end of the article. Figure S1 . Scatter plot showing the relationship between log-transformed pulmonary vascular resistance (PVR) and pulmonary arterial capacitance (PAC) for patients with mean pulmonary artery wedge pressure (mPAWP) ≤ 15 mmHg vs. > 15 mmHg. There is a downward-leftward shift of the PVR-PAC relationship with higher mPAWP. Table S1 . Univariate and multivariate Cox regression analysis with mortality as the dependent variable (n = 487) where pulmonary arterial capacitance instead of CpcPH was entered into the model. Table S2 . Univariate and multivariate Cox regression analysis with mortality as the dependent variable (n = 487) where pulmonary vascular resistance instead of CpcPH was entered into the model.
